Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed
September 20, 2024 08:43 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 20 September 2024 – Novo Nordisk today announced headline results from a phase 2a clinical trial with monlunabant, a small molecule oral cannabinoid receptor 1 (CB1) inverse...
U.S. Dental Services Market Review and Forecast 2019-2029: Southern U.S. Dominating with Rapidly Growing Population and Increasing Oral Health Awareness
September 20, 2024 07:31 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "United States Dental Services Market 2019-2029F" report has been added to ResearchAndMarkets.com's offering.United States' Dental Services Market was...
Avante to Participate at the GSX 2024 Conference
September 20, 2024 07:30 ET
|
Avante Corp.
GSX 2024 takes place on September 23-25, 2024, at the Orange County Convention Center in Orlando, FL. TORONTO, Ontario, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Avante Corp Inc. (TSX.V: XX) (OTC:...
authID Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 19, 2024 16:00 ET
|
authID Inc.
Denver, Sept. 19, 2024 (GLOBE NEWSWIRE) -- authID Inc. (Nasdaq: AUID), a leading provider of biometric identity verification and authentication solutions, today announced the grant of non-qualified...
Novo Nordisk A/S: Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function
September 19, 2024 15:10 ET
|
Novo Nordisk A/S
Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function Wegovy® (semaglutide 2.4 mg) is the first...
Basic Needs Giving Partnership awards new grants of $2.85 million to end poverty
September 19, 2024 14:42 ET
|
U.S. Venture
Appleton, Wis., Sept. 19, 2024 (GLOBE NEWSWIRE) -- The Basic Needs Giving Partnership recently announced their 2024 multi-year grant awards with $2.85 million awarded to 12 organizations across...
DNA and RNA Extraction Market Is Expected To Reach Revenue Of USD 16.4 Bn By 2033, At 8.4% CAGR: Dimension Market Research
September 19, 2024 13:51 ET
|
Dimension Market Research
New York, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Market Overview The Global DNA and RNA Extraction Market is projected to reach USD 7.9 billion in 2024 and is expected to grow to USD 16.4 billion by...
Business Collaborative for Brain Health Partners with HERO to Launch the Brain Health Best Practice Score for Employers
September 19, 2024 13:30 ET
|
UsAgainstAlzheimer's
New educational tool will help companies assess how well their health and well-being programs support their workforce’s brain health, a critical factor in employees’ overall health, performance and...
Low Carbon Propulsion Market is expected to reach a revenue of USD 139.8 Bn by 2033, at 21.8% CAGR: Dimension Market Research
September 19, 2024 13:23 ET
|
Dimension Market Research
New York, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Overview: The Low Carbon Propulsion Market size is expected to reach USD 23.8 billion by 2024 and is further anticipated to reach USD 139.8...
Rejuveron Life Sciences AG Rebrands as Centenara Labs AG and Provides Latest Clinical Updates
September 19, 2024 10:00 ET
|
Centenara Labs AG
Shareholders approve name change and rebranding to Centenara Labs AG (“Centenara”)Rebrand positions business for strategic initiatives designed to support development of therapies for regenerative...